Oligonucleotides targeting myostatin (MSTN)

CA3328204A1Undetermined Publication Date: 2025-11-06UNIV OF MASSACHUSETTS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3328204
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-02
Filing Date
2025-05-02
Publication Date
2025-11-06
Patent Text Reader

Abstract

Provided herein are oligonucleotides (e.g., siRNA) targeting MSTN. Also provided are methods of treating a disease associated with MSTN expression.
Need to check novelty before this filing date? Find Prior Art